Document Detail

Amphetamine and 2-phenylethylamine in post-mortem Parkinsonian brain after (-)deprenyl administration.
MedLine Citation:
PMID:  745019     Owner:  NLM     Status:  MEDLINE    
Deprenyl is an inhibitor of monoamine oxidase type B, the enzyme responsible for 2-phenylethylamine oxidation, and is used in conjunction with L-Dopa therapy in Parkinson's disease. Post-mortem studies in human brain tissue have shown that after (-)deprenyl administration to parkinsonian patients amphetamine is present in concentrations up to 56 ng/g. It also could be shown that phenylethylamine concentrations are substantially increased in such patients. Phenylethylamine and amphetamine have been investigated using a gas chromatographic technique.
G P Reynolds; P Riederer; M Sandler; K Jellinger; D Seemann
Related Documents :
8304969 - Antileishmanial activity and modification of hepatic xenobiotic metabolizing enzymes in...
7590529 - Mechanisms of indole-3-carbinol (i3c) anticarcinogenesis: inhibition of aflatoxin b1-dn...
4402349 - Tyrosine hydroxylase in human adrenal and pheochromocytoma: localization, kinetics, and...
7311169 - Effect of tris (hydroxymethyl) aminomethane on amine oxidase activity in dog brain, liv...
16813579 - The role of phloem sieve elements and laticifers in the biosynthesis and accumulation o...
7205149 - Evaluation of the assay for serum monoamine oxidase -- an index of hepatic fibrosis.
22231989 - Distribution, crypticity, stability, and localization of α-l-fucosidase of mouse cauda...
1179159 - Distribution of disaccharidases, alkaline phosphatase, and some intracellular enzymes a...
17071629 - Glutathione s-transferase phenotypes in relation to genetic variation and fruit and veg...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of neural transmission     Volume:  43     ISSN:  -     ISO Abbreviation:  J. Neural Transm.     Publication Date:  1978  
Date Detail:
Created Date:  1979-05-23     Completed Date:  1979-05-23     Revised Date:  2014-06-03    
Medline Journal Info:
Nlm Unique ID:  0337042     Medline TA:  J Neural Transm     Country:  AUSTRIA    
Other Details:
Languages:  eng     Pagination:  271-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Amphetamines / metabolism*
Brain / metabolism*
Parkinson Disease / drug therapy*,  metabolism
Phenethylamines / metabolism*,  therapeutic use*
Selegiline / therapeutic use*
Reg. No./Substance:
0/Amphetamines; 0/Phenethylamines; 14611-51-9/Selegiline

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Overview of present day treatment of Parkinson's disease.
Next Document:  Cellular junctions in human oesophageal epithelium.